EUVIMEDEUVIMED entdecken
Crossref

L26/P-138 Preliminary Embryological and Implantation Outcomes of Progesterone versus GnRH Antagonist for LH Suppression in IVF Cycles

R. Aslanova, K. Mammadli, K. Niftiyev

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von R. Aslanova und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does progesterone-based LH suppression result in comparable embryological and implantation outcomes to GnRH antagonist protocols in IVF cycles? Summary answer Progesterone-based LH suppression showed similar embryological outcomes but lower implantation rates compared with GnRH antagonist protocols in IVF cycles. What is known already GnRH antagonist protocols are widely used to prevent premature LH surge during controlled ovarian stimulation. Progesterone-based LH suppression has emerged as an alternative approach. Progesterone suppresses LH secretion via negative feedback on the hypothalamic–pituitary axis. While previous studies suggest acceptable clinical outcomes with progesterone-based protocols, concerns persist regarding their effects on oocyte competence, embryo development and implantation. Direct comparisons of detailed embryological parameters and implantation outcomes between progesterone and GnRH antagonist protocols remain limited. Study design, size, duration This retrospective observational study included 256 IVF/ICSI cycles performed at a single IVF center over a defined study period. Cycles were grouped according to the method of LH suppression used during ovarian stimulation. Participants/materials, setting, methods Women undergoing IVF/ICSI cycles using either progesterone (PPOS group, n = 125) or GnRH antagonist (GnRH antagonist group, n = 131) for LH suppression were included. Embryological parameters and implantation outcomes were compared between groups. Main results and the role of chance Baseline characteristics were comparable between groups. No significant differences were observed in the number of retrieved oocytes, number of mature (MII) oocytes, or fertilization outcomes. Fertilization rates were 84% in the PPOS group and 85.9% in the GnRH group. Blastocyst quality distribution differed significantly between protocols. The GnRH antagonist group demonstrated a higher proportion of A-grade blastocysts (3AB, 4AB, 5AB, 6AB, 3BA, 4BA, 5BA, 6BA, 1AA, 2AA; p = 0.024), whereas the PPOS group showed a higher proportion of B-grade blastocysts (3BB, 4BB, 5BB, 6BB; p = 0.033). Implantation rates were significantly higher in the GnRH antagonist group (14.4%) compared with the PPOS group (9.4%) (p = 0.017). Limitations, reasons for caution The retrospective design and single-center setting may limit generalizability. Residual confounding factors cannot be fully excluded. Wider implications of the findings Progesterone-based LH suppression may be an alternative to GnRH antagonist protocols with comparable embryological outcomes; however, implantation differences require confirmation in prospective randomized studies. Trial registration number No

Zitieren

APA

Aslanova, R., Mammadli, K., & Niftiyev, K. (2026). L26/P-138 Preliminary Embryological and Implantation Outcomes of Progesterone versus GnRH Antagonist for LH Suppression in IVF Cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.474

Vancouver

Aslanova R, Mammadli K, Niftiyev K. L26/P-138 Preliminary Embryological and Implantation Outcomes of Progesterone versus GnRH Antagonist for LH Suppression in IVF Cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.474

BibTeX
@article{Aslanova2026,
  author = {Aslanova, R. and Mammadli, K. and Niftiyev, K.},
  title = {L26/P-138 Preliminary Embryological and Implantation Outcomes of Progesterone versus GnRH Antagonist for LH Suppression in IVF Cycles},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.474}
}
Kostenlos starten →